Cite
MLA Citation
Michael R Savona et al.. “An oral fixed-dose combination of decitabine and cedazuridine in myelodysplastic syndromes: a multicentre, open-label, dose-escalation, phase 1 study.” Lancet, vol. 6, no. 4, 2019, pp. e194–e203. http://access.bl.uk/ark:/81055/vdc_100079602891.0x000006